Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors

Diagnostic Cytopathology

Volumn 39, Issue 8, 2011, Pages 562-566

  Yuan, Yuan ^a   Leszczynska, Magdalena ^a   Konstantinovsky, Sophya ^b   Tropé, Claes G ^a,c   Reich, Reuven ^b,d   Davidson, Ben ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c UNIVERSITY OF OSLO   (Norway)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

breast carcinoma; effusion; Netrin 4; ovarian carcinoma; survival; tumor progression

Indexed keywords

NETRIN; NETRIN 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CARCINOMA CELL; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MIXED MULLERIAN TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; SOLID TUMOR; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ASCITIC FLUID; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MIDDLE AGED; MIXED TUMOR, MULLERIAN; NERVE GROWTH FACTORS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 79960402692     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21424     Document Type: Article

References (23)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. Cancer Registry of Norway. Cancer in Norway 2006 - Cancer incidence, mortality, survival and prevalence in Norway, Oslo: Cancer Registry of Norway, 2007.
3. Fentiman IS, Millis R, Sexton S, et al. Pleural effusion in breast cancer: A review of 105 cases. Cancer 1981; 47: 2087-2092. (Pubitemid 11153451)
4. Raju RN, Kardinal CG,. Pleural effusion in breast carcinoma: Analysis of 122 cases. Cancer 1981; 48: 2524-2527. (Pubitemid 12228019)
5. Wilkes JD, Fidias P, Vaickus L, et al. Malignancy-related pericardial effusion. 127 cases from the Roswell Park Center Institute. Cancer (Phila) 1995; 76: 1377-1387.
6. Buck M, Ingle JN, Giuliani ER, et al. Pericardial effusion in women with breast cancer. Cancer 1987; 60: 263-269. (Pubitemid 17092268)
7. Kamby C, Vejborg I, Kristensen B, et al. Metastatic pattern in recurrent breast cancer. Special reference to intrathoracic recurrences. Cancer 1988; 62: 2226-2233. (Pubitemid 18261865)
8. Chédotal A, Kerjan G, Moreau-Fauvarque C,. The brain within the tumor: New roles for axon guidance molecules in cancers. Cell Death Differ 2005; 12: 1044-1056. (Pubitemid 41065422)
9. Cirulli V, Yebra M,. Netrins: Beyond the brain. Nat Rev Mol Cell Biol 2007; 8: 296-306. (Pubitemid 46474658)
10. Freitas C, Larrivée B, Eichmann A,. Netrins and UNC5 receptors in angiogenesis. Angiogenesis 2008; 11: 23-29.
11. Konstantinovsky S, Smith Y, Zilber S, et al. Breast carcinoma cells in primary tumors and effusions have different gene array profiles. J Oncol 2010; 2010: 969084.
12. Davidson B, Nielsen S, Christensen J, et al. The role of Desmin and N-cadherin in effusion cytology. A comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 2001; 25: 1405-1412. (Pubitemid 33022056)
13. Davidson B, Reich R, Lazarovici P, Flã?renes VA, Nielsen S, Nesland JM,. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provides the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Res Treat 2004; 83: 119-128. (Pubitemid 38161258)
14. Davidson B, Konstantinovsky S, Nielsen S, et al. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients - A novel model for tumor progression. Clin Cancer Res 2004; 10: 7335-7346. (Pubitemid 39487723)
15. Elloul S, Bukholt Elstrand M, Nesland JM, et al. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 2005; 103: 1631-1643. (Pubitemid 40490024)
16. Konstantinovsky S, Nielsen S, Vyberg M, et al. Angiogenic molecule expression is downregulated in effusions from breast cancer patients. Breast Cancer Res Treat 2005; 94: 71-80. (Pubitemid 41416944)
17. Kleinberg L, FlÃ?renes VA, Skrede M, et al. Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma. Virchows Arch 2006; 449: 31-39. (Pubitemid 43988363)
18. Davidson B, Konstantinovsky S, Kleinberg L, et al. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Gynecol Oncol 2006; 102: 453-461. (Pubitemid 44376656)
19. Kleinberg L, FlÃ?renes VA, Nesland JM, Davidson B,. Survivin, a member of the inhibitors of apoptosis (IAP) family, is down-regulated in breast carcinoma effusions. Am J Clin Pathol 2007; 128: 389-397. (Pubitemid 47479971)
20. Latil A, Chêne L, Cochant-Priollet B, et al. Quantification of expression of netrins, slits and their receptors in human prostate tumors. Int J Cancer 2003; 103: 306-315. (Pubitemid 36076423)
21. Esseghir S, Kennedy A, Seedhar P, et al. Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins. Clin Cancer Res 2007; 13: 3164-3173. (Pubitemid 46944898)
22. Fujikane T, Nishikawa N, Toyota M, et al. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer. Breast Cancer Res Treat 2009 Oct 27 [Epub ahead of print].
23. Davidson B, Reich R, Lazarovici P, et al. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clin Cancer Res 2003; 9: 2248-2259. (Pubitemid 36687650)